Aescap Venture is a private equity general partner firm headquartered in Amsterdam, XX, Netherlands.
Biocartis, a Belgian molecular diagnostics company backed by several VC firms, has listed on the Euronext Brussels.
Orphazyme, a Denmark-based developer of novel therapeutics for the treatment of rare and genetic diseases, raised €20m in Series B funding.
Orphazyme, a Danish pharma company, has raised a €20m Series B funding round from Kurma Partners, Idinvest Partners, Sunstone and others.
Read more news concerning Aescap Venture
A sampling of Aescap Venture portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?